Angiography-derived fractional flow reserve (FFR) uses data from coronary CT angiography images to estimate the functional severity of coronary artery disease/stenosis, offering a non-invasive alternative to traditional, more invasive fractional flow reserve (FFR) measurements. FFRangio is underutilized in interventional oncology. Listen to the discussion on how angiography-based FFR should be integrated into contemporary practice.
Read the article in JSCAI
At the end of this activity, participants should be able to:
Accreditation StatementThe Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit DesignationSCAI designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful CompletionWatch the content and complete the evaluation to obtain credit.Activity TimelineRecord Date: 1/8/2026Publish Date: 2/17/2026Expiration Date: 2/17/2029
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.
SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.